abolish, glucose-stimulated insulin release from primary β-cells (Meng et al., 1997) .
In the present study, we have investigated: (1) the complement of kinesins in clonal β-cell lines and on dense core insulin secretory vesicles; (2) the role of kinesins in insulincontaining vesicle translocation; (3) the importance of vesicle motility for glucose-stimulated secretion; and (4) the role of ATP in regulating kinesin activity. We demonstrate that sustained insulin release requires kinesin-dependent transport of vesicles to the plasma membrane. Moreover, since vesicle movement could be regulated by increases in ATP concentration over the physiological range in permeabilised cells, these data suggest that kinesin may represent a novel target for regulation by glucose in living β-cells (Kennedy et al., 1999) . Regulation of kinesin activity may thus contribute to the KATP channel-independent stimulation of insulin secretion by nutrients (Aizawa et al., 1998; Takahashi et al., 1999; Seghers et al., 2000) 
Materials and Methods
Materials cDNAs encoding the motor domain (340 amino acids) of rat conventional kinesin heavy chain (KHC340) (the homologue of mouse Kif5b) (Hirokawa, 1998) , and KHC340 containing a T93N mutation (KHC mut ) and fused to a histidine-tag (6His) in vector pET17b, was kindly provided by R. Cross (Marie Curie Research Institute, Oxted, UK) (Krylyshkina et al., 2002) . Human growth hormonecontaining plasmid pXGH5 was kindly provided by R. Burgoyne (University of Liverpool) (Fisher and Burgoyne, 1999) . Rabbitpolyconal anti-phogrin antibody raised against the C-terminal domain (amino acids 629-1003) was a kind gift from J. C. Hutton (Barbara Davis Center for Childhood Diabetes, Denver, CO). Cell culture reagents were from Gibco-BRL (Life Science Research, Paisley, UK). Mouse monoclonal anti-green fluorescent protein (GFP) antibody, the human growth hormone (hGH) ELISA Kit, the ECL detection system and all molecular biologicals were obtained from Roche Diagnostics (Lewes, UK). Alexa Fluor 488 or 568 goat anti-mouse, and Alexa Fluor 568 goat anti-guinea pig IgG were from Molecular Probes (Eugene, USA). A rabbit polyclonal antibody that recognises multiple kinesin family members (pan-kinesin), was raised as described (Barroso et al., 2000) . Rabbit polyclonal anti-ubiquitous kinesin (Niclas et al., 1994) was kindly provided by R. Vale (UCSF, San Francisco, CA). Mouse monoclonal anti-human growth hormone and a rabbit polyclonal His-probe antibodies were from Autogen Bioclear UK (Calne, UK). Mouse monoclonal anti-α-tubulin and anti-dynein (Clone 70.1) antibodies were obtained from Sigma (Poole, UK). A trans-Golgi network protein 38 (TGN38)-specific antibody was kindly provided by G. Banting (University of Bristol, Bristol, UK).
Cell culture MIN6 and INS-1 pancreatic β-cells were cultured in DMEM and RPMI 1640 tissue-culture medium supplemented with 15% (v/v) and 10% (v/v) fetal calf serum, respectively, plus penicillin (100 units ml -1 ) and streptomycin (0.1 mg ml -1 ) at 37°C in an atmosphere of humidified air (95%) and CO2 (5%) as described previously (Molnar et al., 1995) . MIN6 cells were used between passages #19 and #35.
Plasmids KHC (residues 1-340) (KHC340) and KHC340 carying a T93N point mutation (KHC mut ) and (6His) cDNA (Krylyshkina et al., 2002) was cloned across the XbaI-XhoI sites of pcDNA 3.1(-) and then into the pAdTrack-CMV shuttle vector (He et al., 1998) via XbaI-EcoRV sites ( Fig. 3A,B ; Fig. 8A,B) . Generation of phogrin.pEGFP.N1 (Pouli, et al., 1998) and sub-cloning into a recombinant adenovirus were as described earlier (Tsuboi, et al., 2000) . Plasmid phogrin.DsRed was constructed by digesting phogrin.EGFP.N1 with AgeI and NotI to remove the EGFP-coding sequence, and replacing it with the AgeI/NotI DsRed-coding fragment from pDsRed-N1 (Clontech). Mitochondrially-targeted DsRed was generated by fusion to the Nterminal 33 amino acids of cytochrome c oxidase subunit VIII (Rizzuto et al., 1989) . The leader sequence was removed from plasmid pShuttle-CMV.mLuc (Ainscow et al., 2000) by digestion with NdeI (which cleaved within the CMV promoter region) and HindIII, and ligated into plasmid pDsRed-N1.
Adenoviral infection and immunoadsorption of phogrin.EGFPcontaining vesicles INS-1 or MIN6 cells were infected with the recombinant phogrin.EGFP adenoviral construct at a multiplicity of 30-100 viral particles/cell, for 1 hour. Cells were subsequently used 24-48 hour post-infection when >95% of cells were infected. Cells were scraped into ice-cold buffer A [10 mM morpholeno-sulphonic acid (MOPS), 260 mM sucrose, (pH 6.5) 1 µM phenylmethylsulfonyl fluoride (PMSF), 5 µg ml -1 aprotinin, 5 µg ml -1 leupeptin] then homogenised with a teflon homogeniser and centrifuged at 500 g for 1 minute. The post-nuclear supernatant was further centrifuged at 2400 g for 10 minutes at 4°C and the pellet was resuspended in buffer B (50 mM Hepes, 1 mM EDTA, 150 mM NaCl, 1 µM PMSF, 5 µg ml -1 aprotinin, 5 µg ml -1 leupeptin) to a concentration of 1-2 mg ml -1 . 100-200 µg of this homogenate was pre-cleared with 100 µl of packed Protein-A sepharose in buffer B overnight and then centrifuged at 14,000 g for 3 seconds; the supernatant was then transferred to a fresh tube. Vesicles carrying phogrin.EGFP were specifically adsorbed using a mouse monoclonal anti-EGFP antibody. Anti-EGFP antibody (20 µl) was first incubated with 50 µl Protein-A sepharose in buffer B overnight, and the beads washed three times with buffer B. Pre-cleared samples (150-250 µl) were added to the antibody-bound beads and incubation continued for a further 24 hours at 4°C. Samples were centrifuged at 500 g for 30 seconds, and the immunoadsorbed vesicles were washed four times with buffer B and then analysed by SDS-PAGE and immunoblotting (Varadi et al., 1996) . The following control experiments were performed: immunoadsorption with (1) a rabbit polyclonal anti-phogrin antibody that crossreacts with the cytosolic C-terminal domain of phogrin; (2) mouse monoclonal anti-SREBP antibody (sterol response element binding protein-1 is not associated with dense core secretory vesicles) (AzzoutMarniche et al., 2000) ; (3) rabbit pre-immunsera and (4) without any IgGs but in presence of Protein-A sepharose. The presence of kinesin and dynein in the immunoabsobed vesicle preparation was detected using a polyclonal-pan-kinesin antibody (1:1000), a rabbit polyclonal antiubiquitous conventional kinesin (uKHC) antibody (1:2000) and a mouse monoclonal anti-dynein antibody (1:1000). Immunostaining was revealed with horseradish-peroxidase conjugated anti-rabbit IgG (1:160,000) and anti-mouse IgG (1:40,000) using an enhanced chemiluminescence (ECL) detection system. Transient transfection and assay of human growth hormone (hGH) release INS-1 and MIN6 cells were seeded at a density of 4-6×10 5 /ml on 24-mm-diameter poly-L-lysine-coated coverslips, and cultured overnight. Cells were co-transfected with 0.5 µg hGH-encoding plasmid pXGH5 (Fisher and Burgoyne, 1999) together with 1 µg phogrin-pcDNA3 or the corresponding empty vector (pcDNA3); KHC mut -pAdTrack-CMV or the corresponding empty vector (pAdTrack-CMV); KHC340-pAdTrack-CMV or the corresponding empty vector (pAdTrack-CMV) using 10 µg/ml lipofectamine in Optimem I medium for 4 hours. The cells were cultured for 48 hours in complete growth medium (containing 25 mM glucose) which was then replaced with a 3 mM glucose-containing DMEM medium 12 hours prior to stimulation. For assay of hGH release, cells were washed three times in Krebs-Ringer-Hepes-Bicarbonate (KRH) buffer comprising 140 mM NaCl, 3.6 mM KCl, 0.5 mM NaH2PO4, 0.5 mM MgSO4, 2.0 mM NaHCO3, 3 mM glucose, 10 mM Hepes (pH 7.4) and 1.0 mM CaCl2 equilibrated with O2/CO2 (95:5, v/v) at 37°C. Cells were stimulated by incubating with 1 ml KRH buffer containing 3 mM glucose at 37°C. After 20 minutes, 0.5 ml of supernatant was removed and replaced with a high glucose-containing KRH buffer (37°C) to obtain a final glucose concentration of 16 mM or 30 mM. Cells were stimulated for 20 minutes at 37°C then 0.5 ml medium was removed and replaced with KRH buffer containing 16 mM or 30 mM glucose and further incubated for an additional 70 minutes (90 minute time point). At the end of the incubation, the supernatants were removed and the cells lysed in 600 µl of 0.5% (v/v) Triton X-100 (15 minutes at 22°C). The samples were collected and assayed for total hGH content. hGH assay was carried out using a colorimetric sandwich ELISA method according to the manufacturer's instructions (Roche Diagnostics).
Immunocytochemistry and confocal microscopy Cells were co-transfected with 1 µg plasmid DNA encoding KHC mut or KHC340 and phogrin.DsRed or mitochondrial.DsRed. Immunocytochemistry was performed as described earlier (Pouli et al., 1998) . Images were captured on a Leica TCS-NT confocal laser-scanning microscope attached to a DM IRBE™ epifluorescence microscope using a ×63 PL Apo 1.4 NA oil-immersion objective (Leica, Heidelberg, Germany).
Live cell confocal imaging and image ananlysis Prior to imaging, cells were incubated in KHR buffer containing a stimulatory concentration of glucose (16 mM or 30 mM) for 5 minutes at 37°C. Cells co-expressing (1) phogrin.DsRed and KHC mut -pAdTrack-CMV or the empty vector (pAdTrack-CMV); or (2) mitochondrial-DsRed and KHC mut -pAdTrack-CMV or the empty vector (pAdTrack-CMV) were identified by exciting EGFP at 488 nm and using FITC emission filters. The DsRed fluorescence of the same cells was visualised by exciting at 568 nm and using TRITC (tetramethylrhodamine isothiocyanate) filters for fluorescence emission.
To study the effect of various cytosolic ATP concentrations on vesicle movement, phogrin.EGFP expressing cells were permeabilised for 1 minute at 20°C with 20 µM digitonin in intracellular buffer containing 140 mM KCl, 10 mM NaCl, 1 mM K2HPO4, 2 mM Na-succinate, 20 mM Hepes, 0.5 mM EGTA, 0.27 mM CaCl2, 0.3-4.0 mM MgCl2 and 5.5 mM glucose, pH 7.05. Concentrations of free Ca 2+ and Mg 2+ were calculated using 'Metlig' software (Rutter et al., 1988) to be 0.2 µM and 0.26 mM, respectively.
Images were acquired every 5 seconds for 4 minutes (giving a total of 60 frames) using a Leica TCS-NT confocal laser-scanning microscope. Alternatively, to provide greater temporal resolution, cells were imaged on an UltraVIEW™ Live Cell Confocal Imaging system (PerkinElmer Life Sciences, Boston, MA). In the latter case, images were acquired at a rate of 2 frames second -1 for 30 seconds (60 frames total). The movements of 20 randomly-selected vesicles or mitochondria, that were present in the first image of each recorded sequence, were tracked in each cell using the image analysis software MetaMorph TM (Universal Imaging, West Chester, PA). Fluorescent spots representing DsRed-labeled granules or mitochondria were tracked for 60 frames unless the spot was lost from view or coalesced with another spot. The software displayed the first image in a sequence, and was then directed by mouse click to the granule/mitochondrial structure of interest. The program provided, for each granule tracked, a table of x and y coordinates as function of time. The speed of a given single vesicle or mitochondrion was calculated (µm/s) for images taken on the Leica TCS-NT confocal laser-scanning microscope at the magnification values given. For images acquired on the UltraVIEW TM system, the magnification parameters were set at a constant level, and velocity is given in arbitrary units (Fig. 9B) . Differences between the behaviour of vesicles and mitochondria in control and dominantnegative kinesin-expressing cells were assessed by a χ 2 -test (using Yates's Correction) (Moroney, 1951) on histograms generated from the velocity data ( Fig. 5B; Fig. 6B ). The statistical data for one experimental condition was usually obtained from 6-7 cells.
Measurement of intracellular free Ca 2+ concentration [Ca 2+ ]i and NAD(P)H Changes in [Ca 2+ ]i were measured at 37°C with entrapped Fura-2 (Grynkiewicz et al., 1985) using a Leica DM-IRBI inverted microscope (×40 objective) and a Hamamatsu C4742-995 charge-coupled device camera driven by OpenLab TM software (Improvision, Coventry, UK) (Ainscow et al., 2000) . Cells transfected with KHC mut or the empty vector were loaded with 5 µM Fura-2/AM and 0.1% Pluronic F-127 (BASF, Mount Olive, NJ) for 40 minutes in KRH buffer initially containing 3 mM glucose. Autofluorescence due to NAD(P)H was measured as previously described (Ainscow et al., 2000) .
Results
Immunoadsorption of phogrin.EGFP-containing vesicles EGFP was targeted to the limiting membrane of large dense core insulin secretory vesicles (LDCVs) by fusion at the Cterminus of the trans-membrane spanning LDCV protein, phogrin [phosphatase on the granules of insulinoma cells (Wasmeier and Hutton, 1996) ], to produce chimaeric phogrin.EGFP (Pouli et al., 1998) . Confirming the correct targeting of phogrin.EGFP to LDCVs, >95% of the expressed protein was localised to insulin-containing structures in both INS-1 (Pouli et al., 1998; Tsuboi et al., 2000) and MIN6 cells, and no phogrin.EGFP-positive/insulin-negative structures were revealed in >100 single cells examined.
Insulin-containing vesicles were prepared from MIN6 and INS-1 cells by immunoadsorption of the phogrin.EGFP chimaera (see Materials and Methods) using either antiphogrin ( Fig. 1a -e, P) or anti-EGFP antibodies ( Fig. 1a -e, GFP). In homogenates (Hom.) from phogrin.EGFP-virusinfected cells, both antibodies bound to a diffuse band migrating with a molecular mass of 82-86 kDa, corresponding well to the expected size of the chimaera (Fig. 1a ,b, Hom.). This band was completely absent in homogenates from noninfected cells (not shown). As expected, anti-phogrin antibody also crossreacted with endogenous phogrin with molecular weight 60-64 kDa (Fig. 1a, Hom. ). Since the anti-EGFP antibody bound to the phogrin.EGFP chimaera exclusively, this antibody was routinely used for immunoadsorption.
Following immunoadsorption with the anti-EGFP antibody, a single 82-86 kDa band was labelled in the resulting immunoprecipitated fraction with either anti-phogrin or anti-EGFP antibodies (Fig. 1a, b, GFP) . No detectable phogrin.EGFP chimaera was observed in control samples in which immunoadsorption performed with an irrelevant monoclonal antibody (raised to sterol response element binding protein 1; SREBP1) (AzzoutMarniche et al., 2000) (Fig. 1a,b , Cont.), or in the presence of Protein-A sepharose without IgGs, not shown) with either antibody. Furthermore, the immunoadsorbed samples showed intense immunostaining for insulin (Fig. 1c, P, GFP) . These samples were next tested for the presence of the most likely contaminating organelles, mitochondria and lysosomes. Neither mitochondrial glycerol phosphate dehydrogenase-(mGPDH) nor lysosomal antimannose-6-phosphate receptor (M6PR)-specific antibodies revealed detectable amounts of these marker proteins in the immunoadsorbed samples, which revealed that the immunoadsorption protocol provided a preparation of insulincontaining vesicles of high purity, (Fig. 1d ,e, P, GFP), while both antigens were abundant in cell homogenates (Fig. 1d ,e, Hom.).
Conventional kinesin is associated with insulincontaining granules in β-cell lines Expression of conventional kinesin in MIN6 or INS-1 cells, and its association with phogrin.EGFP-containing vesicles, were examined by immunoblot analysis of cell homogenates and purified secretory vesicles, respectively ( Fig. 2A) . Two kinesinJournal of Cell Science 115 (21) specific antibodies were used: (1) a pan-kinesin antibody, raised against a conserved region of the motor domain, and which crossreacts with conventional kinesin heavy chain as well as with a range of kinesin-related proteins (Barroso et al., 2000; Sawin et al., 1992) ; and (2) an anti-ubiquitously expressed) conventional kinesin heavy chain (uKHC) antibody, which was raised against the less conserved regions of the α-helical coiledcoil domain of conventional KHC (Niclas et al., 1994) . The pankinesin antibody crossreacted with a protein migrating with molecular mass ~120 kDa in the immunoadsorbed samples without labelling any other kinesin or kinesin-related protein ( Fig. 2A, left panel, GFP) . However, this antibody labelled several other, presumably kinesin-related proteins, in INS-1 cell homogenates ( Fig. 2A, left panel, Hom. ). The anti-uKHC antibody also crossreacted with the 120 kDa protein in INS-1 cell homogenate ( Fig. 2A, middle panel, Hom. ) and immunoadsorbed samples ( Fig. 2A, middle panel, GFP) . Immunocytochemistry of INS-1 cells with the uKHC antibody also revealed, in agreement with the above data, that a small proportion of conventional kinesin (10-20% of total) is associated with insulin-containing vesicles (Fig. 2B) .
To confirm that the relatively small proportion of total conventional kinesin that was associated with vesicles ( Fig. 2A , left and middle panels, GFP) did not result from contamination with cytosol, we screened the vesicle fraction with an antibody to an abundant cytosolic protein, dynein. While dynein immunoreactivity was abundant in the cell homogenate ( Fig. 2A, right panel, Hom.), this immunoreactivity was undetectable in the vesicle preparation ( Fig. 2A , right panel, GFP) (note that the strongly labelled ~60 kDa band corresponds to IgG). Dominant-negative-acting kinesin (KHC mut ) does not affect the sub-cellular localisation of membrane-bound organelles cDNA encoding the motor domain of rat KHC, carrying a point-mutation (T93N) and a 6His-tag (KHC mut ), was introduced into INS-1 or MIN6 cells alone or with cDNA encoding EGFP (on the same plasmid) (Fig. 3A,B) . The subcellular localisation of the KHC mut protein in INS-1 cells was studied by immunocytochemistry using an anti-6His-tag and an anti-α-tubulin antibodies (Fig. 3A,a-f) . As expected, anti6His-tag antibody showed a filamentous staining pattern (Fig.  3A,a,d ) and most of the over-expressed KHC mut (>90%) localized to microtubules (Fig. 3A,c,f) .
Since kinesin is thought to be involved in membrane transport to the plus-end of microtubules (anterograde transport), we determined whether over-expression of mutant kinesin caused a generalised blockade of membrane transport in the cells. Mitochondria, which have been suggested to move along MTs in other cell types (Ball and Singer, 1982) were visualised by monitoring the fluorescence of mitochondrially targetted DsRed (see Materials and Methods). As shown in Fig. 3 , mitochondria in INS-1 or MIN6 cells transfected with KHC mut (Fig. 3Ba) , empty vector (Fig.  3Bd) or KHC340 (not shown), were widely distributed throughout the cytoplasm in each case. In marked contrast, however, KHC mut overexpression in HeLa cells, to levels comparable with those obtained in INS-1 or MIN6 cells, induced the collapse of mitochondrial structure to the perinuclear region (Fig. 3Bc,d) .
We next determined the effect of KHC mut expression on the distribution of LDCVs as well as proximal elements of the secretory pathway. Insulincontaining vesicles were visualised after cell fixation with an anti-insulin antibody (Fig. 4a-f) or, in live cells, by expressing a phogrin.DsRed chimaera (Fig.  5A ). No evident difference in the intensity or pattern of insulin staining was apparent in cells transfected with either mutant kinesin or empty vector, suggesting that the synthesis and targeting of insulin was not impaired by inhibition of kinesin function. Moreover, the distribution of phogrin.DsRed-labelled secretory vesicles was unaffected in live cells by expression of mutant kinesin (Fig. 5A ), although we occasionally (in 5-10% of cells) observed accumulation of vesicles towards the centre of mutant-kinesin-tranfected cells expressing very high levels of KHC mut (not shown). Stained with an anti-TGN38 antibody, perinuclear localisation of the trans-Golgi network was observed in both KHC mut-expressing cells and non-transfected cells ( Fig. 4g-i) . Thus, the assembly and position of the Golgi apparatus was unaffected by introduction of KHC mut .
Dominant-negative kinesin blocks glucosestimulated excursions of insulin-containing granules but has no effect on mitochondrial motion To study the effect of a mutant kinesin on insulin-containing vesicle movement in real time, β-cells were transfected with cDNAs encoding phogrin.DsRed in the presence or absence of an expression construct encoding mutant kinesin. Importantly, expression of phogrin.DsRed had no impact on either the early or late phases of glucose-stimulated hGH secretion (not shown) demonstrating that this construct is unlikely to perturb vesicle recruitment to sites of exocytosis (not shown).
To quantitate the impact of the mutant kinesin on secretory granule movement (Fig. 5) , live cell imaging was performed first using confocal microscopy. As previously described (Pouli et al., 1998) in the presence of stimulatory glucose concentrations >5 mM) vesicles displayed both short oscillatory movements (<1-2 vesicle diameters) but also longer excursions (several microns). The latter excursions were completely absent at low glucose concentrations (Pouli et al., 1998) . Averaged in a random sample of the whole vesicle population of single cells, vesicles travelled a significantly shorter distance per unit time (χ 2 =P<0.1%) in mutant kinesintransfected cells than in control cells (Fig. 5Aa-d) . Thus, the majority of vesicles (85%) in the mutant kinesin-expressing cells moved with velocities of 0.2 µm second -1 or less, and no vesicle moved more than 0.4 µm second -1 (Fig. 5B) . By contrast, 38% of vesicles in control cells moved 0.2 µm second -1 , 27% travelled 0.4 µm second -1 , and 35% of the vesicles (versus 0% after introduction of KHC mut ) moved more than 0.4 µm second -1 (Fig. 5B) . By contrast, mitochondrial movement (which was insensitive to glucose concentration; E.K.A. and G.A.R., unpublished) was not significantly affected (χ 2 =P>5%) by the expression of the mutant kinesin (Fig.  6A,B) . These data suggest that, in the clonal β-cell lines examined here, conventional kinesin plays an important role in the activitation of secretory vesicle movement by elevated glucose concentrations.
Conventional kinesin is important for the sustained phase of glucose-stimulated secretion from β-cells We next investigated how the reduced vesicle motility, caused by the inhibition of kinesin function, may affect glucosestimulated insulin secretion. In contrast to whole islets (Curry et al., 1968) insulin release in which the early (KATP-channel-dependent) phase of release (Asfari et al., 1992 ) is followed by sustained release of the hormone with no clear nadir between the two phases. To distinguish the effects of kinesin on the first and sustained phases of hormone release in these two cellular models, we co-transfected cells with cDNAs encoding hGH and dominant-negative kinesin (see Materials and Methods), and monitored the release of hGH after either 20 or 90 minutes. hGH released during these two different periods was then taken as a guide to the two phases of insulin release. As revealed by immunocytochemistry (Fig. 7A) , expressed hGH was correctly targeted into dense core vesicles of the regulated secretory pathway, and KHC mut was efficiently introduced into all cells expressing hGH. Thus, of 150 cells examined that expressed EGFP, all were positive for the 6His-tag of KHC mut (not shown). Furthermore, the majority of cells (135 of 150 from three independent experiments) showed positive staining for both hGH and 6His-tag (not shown). Providing further confirmation that introduction of KHC mut did not inhibit the correct targeting of hGH (and presumably insulin) into dense core vesicles, the rate of release of hGH was low under basal conditions (2.3±0.15% and 2.7±0.23% for control and KHC mut -transfected INS-1 cells, respectively, at 3 mM glucose; Fig. 7B ). In this cell line, expression of the dominantnegative kinesin strongly reduced the stimulation by 30 mM glucose of hGH release measured after a 90 minute incubation (2.89±0.32 versus 19.62±0.29-fold, for KHC mut -transfected and control cells, respectively; P<0.001 for the effect of KHC mut ) but was without effect on secretion stimulated by 30 mM glucose after a 20 minute incubation (Fig. 7B) .
Similar to INS-1 cells, the rate of release of hGH from MIN6 cells at basal (3 mM) [glucose] was low, and nearly identical in empty vector and dominant-negative kinesintransfected cells (1.26±0.07 versus 1.17±0.13% of total cellular hGH; Fig. 7C ). However, after a 20 minute incubation at 16 mM glucose, hGH secretion was stimulated more than fivefold in both groups (Fig. 7C) , with no significant difference between the two (6.99±0.297 versus 8.53±1.87-fold above the basal release rate for control and KHC muttransfected cells, respectively; Fig. 7C ). Strikingly, after a 90 minute incubation, glucose-stimulated hGH release from dominant-negative kinesin-expressing MIN6 cells was almost abolished (3.35±0.24 versus 40.61±0.18-fold, for KHC mut -transfected and control cells, respectively; P<0.001; Fig. 7C ).
To determine whether the effect of KHC mut was due specifically to a dominant-negative action of this protein on endogenous KHC we next overexpressed wild-type KHC340, which did not carry the T93N point mutation (Fig. 8A) , and studied its effect on vesicle movements and secretion. This protein showed homogenous cytosolic staining in β-cells (Fig. 8A) and, as expected, did not strongly localise to the (Fig. 5Aa,c ), see ftp://researcher@137.222.66.116/ (log on as 'researcher', password cl100cs, directory 'kinesin'). microtubules (Fig. 8A ). KHC340 expression had no effect on vesicle movements (Fig. 8B ) or hGH release (Fig. 8C) .
To determine whether the effects of mutant kinesin may be the indirect result of an alteration in glucose metabolism or intracellular Ca 2+ handling, changes in intracellular NAD(P)H or [Ca 2+ ] in response to KCl or prolonged glucose stimulation (90 minutes) were also monitored. No difference was observed between dominant-negative kinesin-and empty vectorexpressing cells (data not shown).
Cytosolic ATP stimulates vesicle movements within the physiological concentration range Since kinesin activity is ATP-dependent, we next explored the possibility that this motor protein may permit vesicle movement to be regulated by changes in cytosolic ATP concentration. We therefore studied the ATP dependence of vesicle movements in permeabilised INS-1 cells (see Materials and Methods). In the complete absence of cytosolic ATP, virtually all vesicle movements stopped (Fig. 9Aa,b, 9B) . Changing the MgATP concentration to 0.1 mM (Fig. 9Ac,d , 9B) significantly (P<0.01) increased the velocity of vesicles. Thus, whereas only 2.5% of vesicles moved more than 0.8 arbitrary distance units frame -1 in the absence of ATP, versus 61.8% at 0.1 mM ATP. By contrast, in the presence of 1 mM MgATP, (which corresponds to the resting cytosolic [ATP] in β-cells) (Kennedy et al., 1999) , (Fig. 9Ae,f, 9B ) the movement of vesicles significantly increased (P<0.01 with respect to zero MgATP) and 17.7% of vesicles moved with a velocity of over 1.6 arbitrary distance units frame -1 at 0.1 mM ATP and 39% at 1 mM ATP. Addition of 5 mM MgATP, a concentration in the range of [ATP] reached in intact β-cells after elevation of [glucose] from 3 mM to 30 mM (Kennedy et al., 1999; Ainscow and Rutter, 2001 ), further increased the velocity of vesicles. Thus, 12.8% of vesicles moved with a velocity of over 2.8 arbitrary distance units frame -1 at 1 mM ATP, whereas 21.7% of vesicles achieved this velocity at 5 mM ATP (P<0.01; Fig. 9Ag,h, 9B ).
Discussion
Conventional kinesin is the principal (+) end-directed regulated secretory vesicle motor protein in two clonal β-cell lines Here we have developed a method by which targeted EGFP can be used for the immunoadsorption and isolation of insulincontaining vesicles. This has allowed us to identify motor proteins that may be responsible for the anterograde Journal of Cell Science 115 (21) translocation of insulin-containing vesicles to the cell surface when glucose concentrations rise. This new method provided a highly pure vesicle preparation that was essentially free of mitochondrial and lysosomal contamination (Fig. 1a-e) . Conventional KHC was abundant in these preparations (Fig. 2) , consistent with earlier studies that showed expression of Kif5b conventional KHC in RIN-m38 and primary mouse β-cells (Balczon et al., 1992; Meng et al., 1997) . By contrast, other members of the kinesin family, clearly present in MIN6 and INS-1 cells revealed by western analysis of whole cell homogenates ( Fig. 2A) , were completely absent from the vesicle preparation. These data therefore strongly implicate conventional kinesin as the motor protein responsible for anterograde transport of vesicles during glucosestimulated exocytosis of insulin (Fig. 2) .
Conventional kinesin is required for stimulated vesicle movement
To explore the functional importance of vesicleassociated kinesin, described above, we overexpressed the motor domain of rat conventional KHC containing a T93N mutation in the catalytic (ATP-binding) site. This construct has previously been shown to function as a dominant-negative inhibitor of kinesin function (Nakata and Hirokawa, 1995; Krylyshkina et al., 2002) . Thus, it has been shown that KHC mut , which is a 'rigor' kinesin, binds tightly to but rarely detaches from MTs, and does not support MT motility in other cell types (Nakata and Hirokawa, 1995; Krylyshkina et al., 2002) . This molecular genetic approach was used in preference to the introduction of anti-kinesin antibodies (Bi et al., 1997) , since it permitted parallel studies of both vesicle movement (Fig. 5 ) and exocytosis from cell populations (Fig. 7) .
Interestingly, KHC mut acted specifically to block glucose-induced, but not un-stimulated, movement of vesicles (Fig. 5) . Thus, KHC mut had no effect on the distribution of vesicles under basal conditions, indicating that transport of vesicles to their location within the cell prior to stimulation is independent of vesicle-type. Moreover, a generalised blockade of MT transport was not observed after KHC mut expression as indicated by the observations that: (1) the localisation of mitochondria, Golgi apparatus and insulincontaining vesicles were all similar in mutant kinesintransfected and control cells (Fig. 3B, Fig. 4, Fig. 6 ); and (2) the synthesis and storage of co-transfected hGH was unaltered (Fig. 7) . Taken together, these observations revealed that KHC mut interferes specifically with the binding of active kinesin to secretory vesicles and their movement in response to elevated glucose concentrations. Interestingly, an earlier study showed that the rigor kinesin specifically blocked anterograde transport of lysosomes in mouse fibroblast L cells (Nakata and Hirokawa, 1995) . Thus a similar, kinesin-dependent mechanism, may be involved in the long range transport of both dense core Following stimulation, the cells were lysed in 0.5% Triton X-100 and assayed for total hGH using a colorimetric sandwich ELISA method. hGH release was expressed as a percentage of the total hGH and was compared with values obtained with the empty vector (pAdTrack-CMV) at 3 mM glucose. Number of transfections for each condition are indicated in the columns. **P<0.001 compared with basal (empty vector at 3 mM glucose). secretory vesicles and lysosomes, although the former would appear to occur only after cell stimulation.
Role of kinesins in mitochondrial distribution and movement in β-cells In common with our own findings in pancreatic β-cells, the rigor kinesin did not affect the localisation of Golgi apparatus, mitochondria or lysosomes in mouse fibroblast L cells (Nakata and Hirokawa, 1995) . In contrast, KHC mut caused a complete collapse of mitochondrial structure in HeLa cells (Fig. 3B) , a phenomenon previously observed in Xenopus and fish fibroblasts (Krylyshkina et al., 2002) , as well as in undifferentiated extra-embryonic cells from KIF5b null mutant mice (Tanaka et al., 1998) . Thus, it would appear that in some cell types, including fibroblasts, normal mitochondrial distribution requires active kinesin and, in particular, KIF5b-driven movement along MTs. However, it seems likely that kinesins play little or no role in the overall distribution of mitochondria in smaller mammalian cells, including β-cells.
We observed relatively slow shortrange movements of the mitochondria in β-cells (Fig. 6) , which can probably be explained in large part by Brownian (thermal) motions (Margineantu et al., 2000) . Thus, the velocities we measured for mitochondrial movements (Fig. 6.) were in the range previously described for mitochondrial motions after the suppression of longer excursions in axons (Ligon and Steward, 2000) . KHC mut expression had no effect on these movements which occurred with the same range of velocities as those of secretory vesicles at low glucose concentrations [data not shown and (Pouli et al., 1998) ] or after introduction of KHC mut . However, longer range movements of mitochondria [which were very rarely observed in the time frame (~5 minutes) of the experiments described here], but which may be important for determining the distribution of mitochondria in the cell, would appear not to be driven primarily by kinesin motors in the islet β-cells.
Importance of conventional kinesin for glucose-stimulated insulin secretion Remarkably, the dramatically reduced Journal of Cell Science 115 (21) motility of vesicles in KHC mutexpressing cells (Fig. 5) did not affect basal secretion or the initial phase of glucose-stimulated growth hormone release in INS-1 or MIN6 cells (Fig. 7) . However, the later (sustained) phase of secretion was completely inhibited by KHC mut in both cell types. These results are most simply interpreted in terms of the two-compartment model for insulin release (Grodsky et al., 1969; Rorsman et al., 2000; Daniel et al., 1999) , as illustrated in Fig. 10 . Since the initial phase of secretion is shown here to be independent of kinesin-driven vesicle transport (Fig. 7B, Fig. 10 ), the vesicles involved must have passed through recruitment steps and be very close to, or functionally docked at, the plasma membrane. By contrast, the requirement for conventional kinesin function for sustained secretion (Fig. 7B) , indicates that this process involves the recruitment of vesicles from an intracellular site away from the membrane (Fig. 7B) . Blockade of kinesin function with a monoclonal antibody against the kinesin motor domain (SUK4) inhibited only the slow (second) phase of Ca 2+ -regulated exocytosis in wounded sea urchins eggs (Bi et al., 1997) , which suggests that this feature of regulated exocytosis is similar in both mammalian cells (INS-1 and MIN6) and those of lower organisms.
While the present studies highlight an important role for kinesin in secretory vesicle movement, it should be noted that they do not exclude a role for other motor proteins, including myosin [ (Iida et al., 1997; Yu et al., 2000; Li et al., 1994) in particular type II (Wilson et al., 1998) or V (Titus, 1997) ], perhaps at a later step in vesicle transport to the plasma membrane. Thus, inhibition of myosin ATPase activity with 2,3-butanedione monoxime significantly decreases secretion from sea urchin embryonic cells (Bi et al., 1997) . Unfortunately, the effect of this inhibitor could not be tested in β-cells in the present study since it also inhibits Ca 2+ -channels under some conditions (Byron et al., 1996) .
Role of vesicle-associated kinesin as a potential ATP sensor in glucose stimulated insulin release Analysis of capacitance changes during the release of caged ATP (Eliasson et al., 1997) and studies with permeabilized cells (Li et al., 1994) have demonstrated that Ca 2+ -induced exocytosis in β-cells is highly dependent on access to cytoplasmic ATP. This requirement is largely confined to the second phase of insulin release (Rorsman et al., 2000) . Our new data (Fig. 9.) suggest that kinesin-driven vesicle transport, which requires the hydrolysis of ATP, may be one site at which glucose-induced increases in [ATP] could act to enhance the second phase of insulin secretion. Thus, vesicle movement was (1) entirely dependent on [ATP] (Fig. 9) ; and (2) was stimulated by [ATP] increases over the range observed during challenge of β-cells with glucose (Kennedy et al., 1999; Detimary et al., 1998 ). An important question is whether, in the β-cell, kinesin may be a direct target of glucose-triggered increases in [ATP] (acting at the catalytic site of the ATPase domain) or an indirect target of the nucleotide [e.g. via a protein kinase (Hisatomi et al., 1996) ]. Future studies will be required to explore these possibilities. (Rorsman et al., 2000) of granules is docked and immediately available for release (releasable pool). However, most of the granules are situated some distance from the plasma membrane in a 'reserve pool' and need to be chemically modified or physically translocated to release sites. (2) Shortly after elevation of [glucose] , granules that are already docked undergo exocytosis and transient stimulation of insulin secretion is observed. (3) Kinesin-dependent vesicle recruitment. Note that the nadir in the rate of secretion between end of exocytosis of vesicles in the releaseable pool (2), and the activation of kinesin-dependent vesicle recruitment (3) is postulated to be longer in islets than cell lines, where the two phases of secretion are not readily distinguished. (4) ATP-dependent mobilisation of granules from the reserve pool via kinesin-mediated transport. This stage represents the sustained release of insulin. (5) KHC mut blocks the transport of granules from the reverse pool by irreversibly binding to microtubules (Nakata and Hirokawa, 1995; Krylyshkina et al., 2002) and inhibits the second phase of insulin release. KHC, kinesin heavy chain; KHC mut , motor domain of kinesin heavy chain containing a T93N point mutation; KLC, kinesin light chain; MT, microtubule.
